Andrew Hollman Meyer, Chief Business Officer: Janux Therapeutics JANX Planned sale · Filed 25/10/28

Trade details

Type: Planned sale notice
Stock: Janux Therapeutics JANX
Person: Andrew Hollman MeyerChief Business Officer
Planned sale date: 25/10/28
Filed: 25/10/28

$455.8K to be sold

Janux Therapeutics trades, last 26 weeks

What else happened in Janux Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/28~25/11/27

Andrew Hollman Meyer's recent trades

Andrew Hollman MeyerChief Business Officer
Planned saleJanux Therapeutics
Planned sale
Janux Therapeutics
JANX
$28.2K
1,877 sh
$28.2K
Filed 04/13
Traded 04/13
Andrew Hollman MeyerChief Business Officer
Planned saleJanux Therapeutics
Planned sale
Janux Therapeutics
JANX
$2.6M
178,767 sh
$2.6M
Filed 01/26
Traded 01/26
Andrew Hollman MeyerChief Business Officer
Planned saleJanux Therapeutics
Planned sale
Janux Therapeutics
JANX
$1.7M
118,122 sh
$1.7M
Filed 01/23
Traded 01/23
Andrew Hollman MeyerChief Business Officer
SellJanux Therapeutics
Sell
Janux Therapeutics
JANX
$25.8K
1,879 sh
$25.8K
Filed 01/02
Traded 01/02
Andrew Hollman MeyerChief Business Officer
Sell10b5-1 planJanux Therapeutics
Sell10b5-1 plan
Janux Therapeutics
JANX
$88.7K
2,700 sh
$88.7K
Filed 25/12/03
Traded 25/12/01

Andrew Hollman Meyer, Chief Officer — plans to sell 16,665 sh of Janux Therapeutics JANX · $455.8K · around 10/28 · 10b5-1 plan | Whalegun